AUGUSTA UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1828-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.augusta.edu
The Role of Endothelin-1 in Sickle Cell Disease
- First Posted Date
- 2016-03-18
- Last Posted Date
- 2020-04-02
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 26
- Registration Number
- NCT02712346
- Locations
- 🇺🇸
Augusta University, Augusta, Georgia, United States
Mechanisms for Vascular Dysfunction and Exercise Tolerance in CF
Not Applicable
Active, not recruiting
- Conditions
- Cystic Fibrosis
- First Posted Date
- 2016-02-24
- Last Posted Date
- 2025-01-28
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 13
- Registration Number
- NCT02690064
- Locations
- 🇺🇸
Georgia Prevention Institute, Augusta, Georgia, United States
Study of FOND Versus FOND+O for the Prevention of CINV in Hematology Patients Receiving Highly Emetogenic Chemotherapy Regimens
Phase 3
Completed
- Conditions
- Complications of Bone Marrow TransplantHematologic Neoplasms
- Interventions
- Drug: Placebo
- First Posted Date
- 2015-12-21
- Last Posted Date
- 2018-08-20
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 108
- Registration Number
- NCT02635984
- Locations
- 🇺🇸
Augusta University Medical Center, Augusta, Georgia, United States
Low Pulse Amplitude Focal ECT (LAP Study)
Phase 3
Completed
- Conditions
- Depression
- First Posted Date
- 2015-10-22
- Last Posted Date
- 2019-06-20
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 11
- Registration Number
- NCT02583490
- Locations
- 🇺🇸
Medical Colleage of Georgia, Augusta University, Evans, Georgia, United States
Neuromodulation Therapy for Fecal Incontinence
Not Applicable
Completed
- Conditions
- Fecal Incontinence
- First Posted Date
- 2015-09-22
- Last Posted Date
- 2019-02-20
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 44
- Registration Number
- NCT02556151
- Locations
- 🇺🇸
Augusta University, Augusta, Georgia, United States
🇬🇧University of Manchester, Manchester, United Kingdom
Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental Stress
Phase 1
- Conditions
- Psychological StressHypertension, Renal
- Interventions
- Drug: Placebo
- First Posted Date
- 2015-05-04
- Last Posted Date
- 2019-06-20
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 50
- Registration Number
- NCT02432339
- Locations
- 🇺🇸
Augusta University, Augusta, Georgia, United States
Effectiveness of Prazosin on the Urinary Sodium Excretion Response to Mental Stress
Phase 2
Completed
- Conditions
- HypertensionStress, PsychologicalBlood Pressure
- Interventions
- Drug: Placebo
- First Posted Date
- 2015-05-01
- Last Posted Date
- 2019-06-20
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 50
- Registration Number
- NCT02431936
- Locations
- 🇺🇸
Augusta University, Augusta, Georgia, United States
Epidiolex and Drug Resistant Epilepsy in Children
- Conditions
- Epilepsy
- First Posted Date
- 2015-03-25
- Last Posted Date
- 2015-04-24
- Lead Sponsor
- Augusta University
- Registration Number
- NCT02397863
- Locations
- 🇺🇸
Georgia Regents University, Augusta, Georgia, United States
Effectiveness of Avapro in Obese Normotensive/Hypertensive African Americans
Phase 2
- Conditions
- Blood PressureHypertensionObesityStress, Psychological
- Interventions
- Other: Placebo
- First Posted Date
- 2015-03-11
- Last Posted Date
- 2019-06-21
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 30
- Registration Number
- NCT02386293
- Locations
- 🇺🇸
Augusta University, Augusta, Georgia, United States
Nonalcoholic Fatty Liver Disease and Atherosclerotic Risk in Children
Not Applicable
Completed
- Conditions
- Overweight and ObesityNon-alcoholic Fatty Liver Disease
- First Posted Date
- 2015-03-09
- Last Posted Date
- 2015-03-09
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 175
- Registration Number
- NCT02383485
- Locations
- 🇺🇸
Georgia Prevention Institute, Augusta, Georgia, United States